iTrack™ ab-interno canaloplasty offers implant-free, canal-based glaucoma surgery that achieves excellent clinical outcomes. iTrack™ removes all points of blockage in the outflow pathway, reducing IOP and dependence on medications.

The iTrack™Advance improves the efficiency of the canaloplasty procedure, with an easy-to-use handpiece making the procedure faster to perform. The iTrack™ Advance connects to the iLumin illumination source.

iTrack™ ab-interno canaloplasty offers implant-free, canal-based glaucoma surgery, for all grades of glaucoma severity. iTrack™ removes all points of blockage in the outflow pathway, reducing IOP and dependence on medications. The iTrack Advance™ improves the efficiency of the canaloplasty procedure, with an easy-to-use handpiece making the procedure faster to perform. It is suitable for the treatment of mild to moderate glaucoma.

The iTrack™ Advance is the latest generation iTrack™ device, which was first introduced in 2008. Today, more than 150,000 iTrack™ procedures have been performed globally. 

Yes, the iTrack™ Advance procedure eliminates the need to remove or tear trabecular meshwork tissue. In addition, it preserves the conjunctiva and angle for any future procedures, if required.

The iTrack™ Advance is designed to treat mild to moderate cases of glaucoma.

Yes, iTrack™ Advance enables titration of OVD volume based on the patient’s pathology. It is the only canaloplasty device that enables surgeons to customise the degree of viscodilation on an individual patient basis, maximising patient outcomes.

The iTrack™ Advance combines 360° microcatheterisation and viscodilation to address all potential points of resistance in the conventional outflow pathway, including; the trabecular meshwork, Schlemm’s canal and the collector channels – and thereby removes the guesswork inherent in stent based MIGS procedures.

Initially 15-20 minutes, although once the user is fully trained, it can be as quick as five minutes.

Yes, the iTrack™ Advance can be used on an eye which already has an iStent in place.

No, the lightbox does not need to be sterilized, it can just be sterile wiped.

No, the iLumin illumination source is a battery-powered device; there is no power cable.

Yes, the iTrack™ Advance is used once and then disposed of.

The iTrack™ Advance can treat double the area of OMNI and delivers 20 times more OVD.

For price information, including a full quotation, please contact the customer services team on 01279 883720 or email sales.uk@haag-streit.com.

Yes, please contact the customer services team on sales.uk@haag-streit.com or call 01279 883720 and we can arrange a demonstration of the device for you.

The iTrack is manufactured by Nova Eye Medical, a company based in California, USA, with a global network of more than 50 distribution partners. Nova Eye's legacy spans more than 30 years in ophthalmology, with a portfolio of proprietary glaucoma treatment technologies. Haag-Streit UK is the sole UK Distributor for the Nova Eye iTrack™ Advance.